Top Markets
Coin of the day
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
Rang in Aktien #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Aktienkurs
$25.61
Zuletzt synchronisiert: 2025-10-10
Marktkapitalisierung
$1.37B
Veränderung (1 Tag)
0.20%
Veränderung (1 Jahr)
1.59%
Land
US
Handel Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Kategorie

Kursverlauf für Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
Höchster Schlusskurs: $25.59 am 2025-10-01

Niedrigster Schlusskurs: $25.61 am 2021-05-01
Kursverlauf der Aktie von Harrow Health, Inc. 8.625% Senior Notes due 2026 von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -0.14%
2025 1.11%
2024 5.61%
2023 0.96%
2022 -11.16%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$60.84 70.81%
US
$52.07 69.60%
SE
$193.46 40.55%
FR
$0.72 -27.92%
HK
$62.45 0.64%
IT